California State Teachers Retirement System Grows Stake in Ralliant Corporation $RAL

Key Points

• California State Teachers Retirement System increased its Ralliant stake by 23.1% in the first quarter, reaching 130,822 shares valued at approximately $5.44 million. Several other institutional investors also initiated or expanded positions.
• Ralliant reported quarterly earnings of $0.68 per share, exceeding analyst expectations of $0.63, on revenue of $567.8 million. The company issued fiscal 2026 EPS guidance of $2.76–$2.90 and declared a quarterly dividend of $0.05 per share.
• Analyst sentiment is generally positive, with a consensus “Moderate Buy” rating and a $75.70 price target. Shares recently opened at $65.92, while targets from TD Cowen and Evercore reached $80, though some analysts maintained hold or sell ratings.

California State Teachers Retirement System grew its stake in shares of Ralliant Corporation (NYSE:RAL - Free Report) by 23.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 130,822 shares of the company's stock after acquiring an additional 24,591 shares during the period. California State Teachers Retirement System owned about 0.12% of Ralliant worth $5,441,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Danske Bank A S acquired a new position in Ralliant in the fourth quarter worth approximately $25,000. Allworth Financial LP boosted its position in Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company's stock worth $26,000 after purchasing an additional 293 shares during the period. V Square Quantitative Management LLC bought a new stake in Ralliant during the fourth quarter valued at about $26,000. Palisade Asset Management LLC bought a new stake in shares of Ralliant in the third quarter valued at approximately $26,000. Finally, Rothschild Investment LLC raised its stake in Ralliant by 98.1% during the 4th quarter. Rothschild Investment LLC now owns 612 shares of the company's stock valued at $31,000 after purchasing an additional 303 shares during the last quarter.

Ralliant Price Performance

Ralliant stock opened at $65.92 on Friday. The business has a 50-day simple moving average of $67.52 and a 200 day simple moving average of $54.72. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75. The stock has a market cap of $7.29 billion, a price-to-earnings ratio of -6.08, a PEG ratio of 2.47 and a beta of 1.60. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $75.41.

Ralliant (NYSE:RAL - Get Free Report) last released its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating analysts' consensus estimates of $0.63 by $0.05. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.The company had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, research analysts forecast that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant's dividend payout ratio is presently -1.84%.

Analysts Set New Price Targets

RAL has been the subject of a number of analyst reports. TD Cowen lifted their price objective on Ralliant from $70.00 to $80.00 and gave the company a "buy" rating in a report on Friday, July 31st. Vertical Research cut shares of Ralliant from a "buy" rating to a "hold" rating and set a $65.00 price target for the company. in a research note on Wednesday, May 27th. Evercore started coverage on shares of Ralliant in a report on Tuesday, June 9th. They set an "outperform" rating and a $80.00 target price for the company. BMO Capital Markets began coverage on shares of Ralliant in a research report on Monday, July 20th. They issued a "market perform" rating and a $78.00 price target for the company. Finally, Weiss Ratings reissued a "sell (d)" rating on shares of Ralliant in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Ralliant presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.70.

Ralliant Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source